Literature DB >> 2988888

Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy.

D A Greene, S Lattimer, J Ulbrecht, P Carroll.   

Abstract

Recent animal and in vitro studies have identified several interrelated metabolic abnormalities in diabetic nerve that are attributable to elevated ambient glucose concentrations. In combination, these metabolic changes may induce a variety of biochemical and biophysical alterations in peripheral nerve that are highly relevant to the pathogenesis of diabetic neuropathy. This article reviews the current status of several of these metabolic defects and describes ways in which their interaction could lead to pathogenetically important changes in nerve metabolism, function, and structure. Areas of related future research are also discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988888     DOI: 10.2337/diacare.8.3.290

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  38 in total

1.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

2.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

3.  Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain.

Authors:  S F Leong; T K Leung
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

4.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

Authors:  A A Sima; V Nathaniel; V Bril; T A McEwen; D A Greene
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

5.  Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.

Authors:  A A Sima; A Prashar; W X Zhang; S Chakrabarti; D A Greene
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 6.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor.

Authors:  T J Faes; G A Yff; O DeWeerdt; P Lanting; J J Heimans; F W Bertelsmann
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

Review 8.  Diabetic neuropathies. Current concepts in prevention and treatment.

Authors:  J D Ward
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

9.  Peripheral nerve function in relation to quality of metabolic control in diabetes.

Authors:  F W Bertelsmann; J J Heimans; J C van Rooy; C Popp-Snijders; E A van der Veen
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

10.  Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion.

Authors:  F W Bertelsmann; J J Heimans; J C Van Rooy; H F Dankmeijer; S L Visser; E A Van der Veen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.